Brought to you by Euractiv's newsroom | The much-anticipated Critical Medicines Act wants to scale up investments in manufacturing capacity for critical medicinal products within the EU and provide the necessary financial incentives, according to a document seen by Euractiv. The Act is due to be presented by EU Health Commissioner Olivér Várhelyi in the European Parliament on Tuesday. Its main objectives are to reduce the EU's foreign dependencies, focus on domestic production of critical medicines and provide the necessary financial framework to accelerate the implementation of relevant projects. Here's what's in the Act: |
|
|
|
|
͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
